How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Non-model organisms are organisms that have not been selected by the research community for extensive study either for historic reasons, or because they lack the features that make model organisms ...

The RNA world hypothesis proposes that early life was based on RNA, which subsequently devolved the storage of information to more stable DNA, and catalytic functions to more versatile proteins.

This copy is for your personal, noncommercial use only. New this week by Maggie Haberman and Jonathan Swan Simon & Schuster Audio Two White House correspondents for The New York Times delve into the ...